Spire Wealth Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-283
Closed -$18.1K – 2256
2026
Q2
$18.1K Buy
+283
New +$14.7K ﹤0.01% 1471

Other funds holding KNSA

Spire Wealth Management's KNSA Position: Q3 2026 in Review

Spire Wealth Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2026, closing a stake of 283 shares — an estimated $18.1K sold.

Spire Wealth Management first reported a position in KNSA in Q2 2026 and held it in 1 quarter. The position peaked at $18.1K in Q2 2026. 300 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Spire Wealth Management reported no remaining Kiniksa Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Spire Wealth Management sold 283 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $18.1K.
  • Spire Wealth Management first reported a position in Kiniksa Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Spire Wealth Management's Kiniksa Pharmaceuticals position peaked at $18.1K in Q2 2026.
  • 300 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.